Cutera (NASDAQ:CUTR) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a report released on Thursday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

CUTR stock opened at $0.44 on Thursday. The company has a market capitalization of $8.86 million, a PE ratio of -0.07 and a beta of 1.32. Cutera has a 12 month low of $0.28 and a 12 month high of $3.10. The firm’s 50-day moving average is $0.41 and its 200 day moving average is $0.64.

Cutera (NASDAQ:CUTR) last posted its earnings results on Thursday, November 7th. The medical device company reported ($1.94) EPS for the quarter, missing analysts’ consensus estimates of ($0.96) by ($0.98). The business had revenue of $32.50 million for the quarter, compared to analyst estimates of $32.57 million. During the same quarter last year, the business earned ($2.22) earnings per share. Sell-side analysts forecast that Cutera will post -5.78 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cutera stock. Bank of Montreal Can raised its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 14.2% during the second quarter, according to its most recent filing with the SEC. The firm owned 282,704 shares of the medical device company’s stock after purchasing an additional 35,248 shares during the period. Bank of Montreal Can owned 1.41% of Cutera worth $455,000 at the end of the most recent reporting period. 90.70% of the stock is owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.